IngenOx Therapeutics - Crunchbase Company Profile & Funding

Overview

IngenOx Therapeutics

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About IngenOx Therapeutics

CB Rank

336323

IngenOx Therapeutics is a new company with both clinical stage programmes and a research pipeline.

Founded

obfuscation

Private

Oxford, Oxfordshire, United Kingdom

11-50

ingenox.com

Clinical Trials

Medical

Therapeutics

Details

Operating Status

Active

Company Type

For Profit

About the Company

IngenOx Therapeutics is a new company with both clinical stage programmes and a research pipeline.

Contact Email

enquiries@ingenOx.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

AT101 (PRMT5 Inhibitor)

AT101 is a small molecule inhibitor targeting PRMT5 enzyme to block cancer cell proliferation, currently in IND-enabling studies and planned for Phase I clinical trials.

Zabadinostat (CXD101)

Zabadinostat is an immuno-modulatory small molecule that enhances immune recognition and destruction of cancer cells, used in clinical trials for various cancers including lymphoma and hepatocellular carcinoma.